Although these results are still preliminary, they establish the platform potential to recapitulate TTP’s abnormal vWF manifestation and coagulation using blood from healthy volunteers, as well as other pathologies that involve endothelial dysfunction. The gene discussed is VWF; the disease is endothelial dysfunction.